The Ebola outbreak in the Democratic Republic of Congo has escalated significantly, with the death toll rising to 600 as of Thursday, according to the World Health Organization (WHO). This marks a sharp increase from just three days prior, when the fatalities had crossed 500. Since the outbreak was declared in mid-May 2026, 1,759 confirmed cases have been reported in the DRC, with the majority concentrated in the northeastern Ituri province.
The outbreak, driven by the rare Bundibugyo strain of Ebola for which no approved vaccines exist, has recorded a 34% case fatality rate. In neighboring Uganda, two deaths have been reported among 20 confirmed cases, with 17 patients recovering. Additionally, 285 individuals in the DRC have recovered, while 304 suspected cases remain under investigation.
The situation is further complicated by the region’s ongoing security challenges, as Ituri province faces persistent threats from armed groups. In response, clinical trials for two experimental treatments—the monoclonal antibody MBP134 and the antiviral drug remdesivir—began on July 2 to evaluate their efficacy against the Bundibugyo strain. The outbreak is the DRC’s 17th documented Ebola crisis and underscores the urgent need for coordinated international health interventions.
Also Read
- PepsiCo earnings miss estimates as North American consumers tighten their budgets
- Digital Euro Advances to Final Negotiation Stage in the EU
- How Lenovo’s AI-powered solutions are directly impacting the FIFA World Cup experience
- US Grants Ukraine License to Manufacture Patriot Missiles for Air Defense

